Epidemiology of inflammatory breast cancer (IBC).

Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer with unknown etiology and generally poor outcome. It is characterized by diffuse edema (peau d'orange) and redness (erythema), although either the disease itself or case definitions have varied over time and place, confounding temporal trends and geographic variations. In this review, we discuss case definitions for IBC and its clinical characteristics; describe its geographic variation, age and racial distribution, incidence and survival patterns, and summarize the very limited information on its epidemiologic risk factors. We also incorporate emerging data from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Program.

[1]  R. Simmons,et al.  Inflammatory local recurrence after breast-conservation therapy for noninflammatory breast cancer. , 2005, American journal of clinical oncology.

[2]  S. Devesa,et al.  Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. , 2005, Journal of the National Cancer Institute.

[3]  S. Steinberg,et al.  Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Levine,et al.  Increasing evidence for a human breast carcinoma virus with geographic differences , 2004, Cancer.

[5]  M. Sherman,et al.  Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  P. Wingo,et al.  Population-Based Statistics for Women Diagnosed with Inflammatory Breast Cancer (United States) , 2004, Cancer Causes & Control.

[7]  B. Kohler,et al.  Variation in breast cancer counts using SEER and IARC multiple primary coding rules , 2004, Cancer Causes & Control.

[8]  G. Hortobagyi,et al.  Inflammatory breast carcinoma: the sphinx of breast cancer research. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  W. Anderson,et al.  Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Nilanjan Chatterjee,et al.  Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database , 2002, Breast Cancer Research and Treatment.

[11]  Robert A. Weinberg,et al.  Metastasis genes: A progression puzzle , 2002, Nature.

[12]  I. Günhan-Bilgen,et al.  Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. , 2002, Radiology.

[13]  M. Rahbar,et al.  Case Control Study of Prognostic Markers and Disease Outcome in Inflammatory Carcinoma Breast: A Unique Clinical Experience , 2001, The breast journal.

[14]  Ruiz Simón Amparo,et al.  Inflammatory Breast Carcinoma: Pathological or Clinical Entity? , 2000, Breast Cancer Research and Treatment.

[15]  D. Easton.  Breast cancer—not just whether but when? , 2000, Nature Genetics.

[16]  J. Bertram,et al.  Molecular Biology of Cancer , 1997, Nature Medicine.

[17]  G. Colditz,et al.  Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. , 2000, American journal of epidemiology.

[18]  A. Buzdar,et al.  Inflammatory Breast Cancer Survival: The Role of Obesity and Menopausal Status at Diagnosis , 2000, Breast Cancer Research and Treatment.

[19]  G. Glinsky,et al.  The role of blood group antigens in malignant progression, apoptosis resistance, and metastatic behavior. , 2000, Transfusion medicine reviews.

[20]  A. Baloush,et al.  Pregnancy-associated breast cancer: a case— control study in a young population with a high-fertility rate , 2000, Medical oncology.

[21]  J. Daoud,et al.  [Breast cancer in Tunisia: clinical and epidemiological study]. , 1999, Bulletin du cancer.

[22]  A. Buzdar,et al.  Inflammatory breast cancer and body mass index. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Buzdar,et al.  Inflammatory breast carcinoma incidence and survival , 1998, Cancer.

[24]  G. Heppner,et al.  Immunological enhancement of breast cancer , 1997, Parasitology.

[25]  J. Julien,et al.  Influence of pregnancy on the outcome of breast cancer: A case‐control study , 1997, International journal of cancer.

[26]  P. Greenwell.  Blood group antigens: molecules seeking a function? , 1997, Glycoconjugate Journal.

[27]  D. Vanel,et al.  Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. , 1997, European journal of radiology.

[28]  P. Rosenberg,et al.  Hazard function estimation using B-splines. , 1995, Biometrics.

[29]  S. Romain,et al.  Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition? , 1995, International journal of cancer.

[30]  H. Stalsberg,et al.  Age distribution of histologic types of breast carcinoma , 1993, International journal of cancer.

[31]  P. Bonnier,et al.  Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR. , 1992, Anticancer research.

[32]  S. Tommasi,et al.  Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease , 1989, Cancer.

[33]  B. Modan,et al.  Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors , 1989 .

[34]  M. Mathieu,et al.  Structure and expression of c‐erbB‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: Prognostic significance , 1989, International journal of cancer.

[35]  M. Henderson,et al.  Secondary Inflammatory Breast Cancer: Treatment Options , 1988, Southern medical journal.

[36]  Chiedozi Lc.  Prognostic significance of exclusive skeletal metastases in stage IV primary carcinoma of the breast. , 1988 .

[37]  Chiedozi Lc.  Rapidly progressing breast cancer in Nigeria. , 1987 .

[38]  B. Fisher,et al.  Pathologic findings from the national surgical adjuvant breast project (protocol 6). Relation of local breast recurrence to multicentricity , 1986, Cancer.

[39]  L. R. Hill,et al.  Inflammatory breast carcinoma: A distinct entity? , 1985, Journal of surgical oncology.

[40]  P. Levine,et al.  Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. , 1985, Journal of the National Cancer Institute.

[41]  P. Levine,et al.  Increased incidence of mouse mammary tumor virus‐related antigen in tunisian patients with breast cancer , 1984, International journal of cancer.

[42]  S. Wells,et al.  Estrogen receptor status in inflammatory breast carcinoma , 1982, Journal of surgical oncology.

[43]  P. Levine,et al.  Histopathological features of rapidly progressing breast carcinoma in Tunisia: A study of 94 cases , 1982, International journal of cancer.

[44]  P. Levine,et al.  Studies on the role of cellular immunity and genetics in the etiology of rapidly progressing breast cancer in tunisia , 1981, International journal of cancer.

[45]  P. Levine,et al.  Epidemiologic features of rapidly progressing breast cancer in Tunisia , 1980, Cancer.

[46]  P. Levine,et al.  Rapidly progressing breast cancer (poussée Évolutive) in Tunisia: Studies on delayed hypersensitivity , 1978, International journal of cancer.

[47]  L. Muenz,et al.  Clinical and prognostic features of a rapidly progressing breast cancer in tunisia , 1977, Cancer.

[48]  S. Saltzstein,et al.  Clinically occult inflammatory carcinoma of the breast , 1974, Cancer.

[49]  S. Teitelbaum,et al.  Inflammatory carcinoma of the breast. A Pathologic Definition , 1974, Cancer.

[50]  C. Gros,et al.  Sex chromatin (Barr body) and inflammatory carcinoma of the breast. , 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[51]  A. Delatorre,et al.  Inflammatory carcinoma of the breast , 1971 .

[52]  P. Rosen,et al.  Inflammatory carcinoma of the breast. , 1974, The Surgical clinics of North America.

[53]  P. Armitage,et al.  A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer , 1957, British Journal of Cancer.

[54]  P. Armitage,et al.  The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.

[55]  N. Treves.  Inflammatory carcinoma of the breast in the male patient. , 1953, Surgery.

[56]  D. Dj.  Carcinoma of the breast. , 1952 .

[57]  Dockerty Mb,et al.  Inflammatory carcinoma of the breast. , 1948, Surgery, gynecology & obstetrics.

[58]  Weber Fp.  Bilateral Thoracic Zosteroid Spreading Marginate Telangiectasia-probably a Variety of "Carcinoma Erysipelatodes" (C. Rasch)-associated with Unilateral Mammary Carcinoma, and better termed "Carcinoma Telangiectaticum". , 1933 .

[59]  G. Learmonth.  Acute Mammary Carcinoma: (Volkmann's Mastitis Carcinimatosa). , 1916, Canadian Medical Association journal.

[60]  E. Schumann.  V. A Study of Carcinoma Mastitoides. , 1911, Annals of surgery.

[61]  J. Bahi,et al.  Breast cancer in women under 30 years of age , 2005, Breast Cancer Research and Treatment.

[62]  N. Chatterjee,et al.  Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  G. Garratty.  Blood group antigens as tumor markers, parasitic/bacterial/viral receptors, and their association with immunologically important proteins. , 1995, Immunological investigations.

[64]  M. Pike,et al.  Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. , 1993, Epidemiologic reviews.

[65]  S. Swain,et al.  Treatment of patients with inflammatory breast cancer. , 1989, Important advances in oncology.

[66]  G. Contesso,et al.  Inflammatory tumors of the human breast: determination of estrogen and progesterone receptors. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[67]  A. Lilienfeld,et al.  The age distribution in female breast and genital cancers , 1955, Cancer.

[68]  C. P. Oliver,et al.  Possible relationship between menopause and age at onset of breast cancer , 1950, Cancer.